Tag Archives: Achilles

Sports

Rui Hachimura trade is a consequence of the Wizards’ Achilles’ heel: poor drafts

Leave a comment

Three and a half years ago, the Washington Wizards had a valuable opportunity to acquire a difference-making player. They held the ninth overall pick in the 2019 NBA Draft. With that pick, they chose Rui Hachimura with the hope of developing him into at least a solid starter they could keep for the long term.

That will not happen now. Washington traded Hachimura to the Los Angeles Lakers on Monday for guard Kendrick Nunn and three future second-round picks. The Wizards also generated a $6.3 million trade exception in the process. While Nunn, his expiring contract, the future picks and the trade exception have utility, their overall value pales in comparison to what the value of 2019’s ninth overall pick was the day it was made.

To put it bluntly: The Wizards will have wasted the opportunity that first-round choice represented if their front office doesn’t somehow flip Nunn, one or more of the incoming second-round picks or the trade exception into a steal of a trade down the line.

Hachimura’s departure would not feel so exasperating if the Wizards could point to at least one significant draft success in recent years. But the sad truth is the team has had five top-15 picks since 2018, and none of the players the team has drafted has shown yet that he will blossom into an upper-level starter in Washington.

Draft futility is the primary reason the Wizards find themselves in the predicament they face now, amid yet another mediocre season. High-performing teams with sustainable rosters tend to draft well. The worst teams consistently draft poorly.

In 2018, the Wizards selected Troy Brown Jr. 15th. They could have chosen guard Anfernee Simons instead.

In 2019, they selected Hachimura.

Cam Johnson went off the board two picks later. Tyler Herro, the 2021-22 NBA Sixth Man of the Year, went 13th. Grant Williams lasted until No. 22. Golden State drafted guard Jordan Poole 28th, and Poole is on the brink of stardom. San Antonio snagged forward Keldon Johnson 29th.

Deni Avdija, a forward Washington picked ninth in 2020, is a solid rotation player who already has made an impact defensively because of his effort, positional size and versatility. But while he has promise as a playmaker, his development on offense has stagnated. The Wizards intend to remain patient with Avdija, who only recently turned 22 years old.

Meanwhile, Tyrese Haliburton, who was drafted three picks after Avdija, has grown into a likely All-Star point guard following a trade from Sacramento to Indiana. Tyrese Maxey (drafted 21st) is a highly coveted guard with Philadelphia. Desmond Bane, the final pick of the first round, has helped Memphis become one of the best teams in the Western Conference.

In 2021, Washington drafted Corey Kispert 15th, and Kispert has met expectations as a long-range shooter and floor-spacer. But he is not a future star. To be fair, few players selected after Kispert in that draft look like future stars, either, although Quentin Grimes, Bones Hyland and Herb Jones — all drafted from No. 25 to No. 35 — have exceeded expectations, especially on the defensive end.

Of course, drafting retrospectively is 100 percent easier with the gift of hindsight. I’m not suggesting that drafting well is easy. I’m not claiming I could have done better. Anyone can identify Haliburton as a future All-Star now that he’s averaging 20.2 points and 10.2 assists this season and elevated the supposedly tanking Indiana Pacers into playoff position before he suffered elbow and knee injuries on Jan. 11.

The Wizards should not be held accountable for not hitting on all of their recent draft picks. Even the teams that draft best do not have immaculate track records. No team is perfect.

But over the last decade, Washington has been nowhere close to even below average with its drafting. Washington has not had a major draft success since it selected John Wall first overall in 2010 and Bradley Beal third overall in 2012.

Otto Porter Jr., the third pick by the Wizards in 2013, turned out to be a solid rotation player. But it’s impossible to ignore that CJ McCollum went 10th and that two-time NBA MVP Giannis Antetokounmpo went 15th.

The high-profile misses — including the sixth pick in 2011, Jan Veselý, who lasted only 162 games in the NBA before he returned to Europe — are the primary reason for the franchise’s mediocrity. The Wizards have tended to struggle to lure quality free agents, but teams that struggle in free agency attempt to compensate by acing the draft.

And now the Wizards are in danger of having another Veselý-level whiff. Johnny Davis, the 10th pick last summer after he was the Big Ten Player of the Year as a sophomore at Wisconsin, not only has been unable to earn NBA minutes but also is producing unimpressive numbers in the G League. Davis is only 20 years old, and scouts correctly point out that he had a mediocre freshman season in college before he blossomed the following year. Still, the initial returns of Davis’ play are worrisome.


Johnny Davis, the 10th pick in the 2022 NBA Draft, has struggled so far as a pro. (Yukihito Taguchi / USA Today)

Hachimura has shown some promise. He has recorded four 30-point games as a pro, including on Saturday, which turned out to be his final game with the Wizards.

His development in Washington faced several significant hurdles. An injury interrupted his rookie season. Then, the pandemic broke up his rookie season and shortened the offseason heading into his second year. Last season, he missed Washington’s first 39 games on an excused absence to attend to a personal matter following his stint playing for Japan in the Summer Olympics in Tokyo. Wizards officials could not have been more supportive of him during that difficult time. In retrospect, however, those missed games slowed his growth.

You could make the argument that Hachimura still would be with the Wizards right now if the team hadn’t traded for Kyle Kuzma in 2021 in the massive deal that sent Russell Westbrook to the Lakers. Without Kuzma in the fold, Hachimura would have received more playing time and might not have wanted to be traded.

But at the same time, it would be difficult to make the case that the Wizards ever came close to developing Hachimura’s potential on the defensive end or coaxing him out of being a selfish player on the offensive end.

That’s on Hachimura, but it’s also on the Wizards.

Team officials would argue — correctly — that they still have a chance to make good on their 2019 first-round pick, even with Hachimura now gone. Nunn’s expiring contract could make it easier for the Wizards to re-sign Kuzma in July and build out their roster without going into the luxury tax. One or more of the incoming second-round picks could provide grist for a trade or trades down the line. A trade exception worth $6.3 million is a valuable roster-construction tool.

Wizards president and general manager Tommy Sheppard, who has led the franchise’s basketball operations department since mid-2019, has specialized in converting bad contracts or bad signings into positives.

He managed to trade John Wall’s supposedly untradable salary and a future protected first-round pick to Houston for Russell Westbrook.

Indeed, the Wizards wound up trading Brown, who had been their first-round pick in 2018, to Chicago in a three-team deal that brought center Daniel Gafford to Washington.

During the offseason that followed, Sheppard flipped Westbrook’s massive salary in a creative, and massively complex, five-team trade that netted the Wizards a large number of rotation players on smaller contracts, including Kuzma and Kentavious Caldwell-Pope, and also allowed them to complete a sign-and-trade for Spencer Dinwiddie.

When the Dinwiddie addition flamed out spectacularly, Sheppard found a way to package Dinwiddie and Dāvis Bertāns to Dallas for Kristaps Porziņģis and a second-round pick. Porziņģis has played close to an All-Star level this season.

So it wouldn’t be out of the ordinary for Sheppard to find a creative use for Nunn, Nunn’s expiring contract, the incoming second-round picks or the trade exception.

But despite Sheppard’s creative trade gymnastics, the Wizards need to find ways to avoid operating from less-than-ideal positions, such as having the Wall contract on their books or Dinwiddie not meeting expectations.

It didn’t have to be this way, with the Wizards careening toward yet another mediocre season and remaining far away from contending for a conference title.

They needed to draft better, as the Hachimura trade once again demonstrated.

Related reading

Buha: How this move helps Los Angeles now and later

Harper: Lakers, Wizards swing trade for Rui Hachimura: Grades and reaction

Leroux: In Rui Hachimura trade, $18.8 million cap hold looms large for Lakers

Charania and Aldridge: Wizards trade Rui Hachimura to Lakers: Why deal makes sense for him

Related listening

(Top photo of Rui Hachimura and Dorian Finney-Smith: Tommy Gilligan / USA Today)



Read original article here

Sports

Bucs LB Shaquil Barrett out for season with torn Achilles, source says

Leave a comment

TAMPA, Fla. — Tampa Bay Buccaneers outside linebacker Shaquil Barrett will miss the rest of the 2022 season after suffering a torn Achilles, a source told ESPN’s Adam Schefter on Friday.

An MRI on Friday confirmed the Achilles tear, with the source saying Barrett is expected to be out seven to nine months.

Barrett was injured on a third-and-1 run play during the third quarter of Thursday’s 27-22 loss to the Baltimore Ravens. After being attended to by athletic trainers, Barrett came off the field while barely putting any weight on his lower left leg and was carted off to the locker room once on the sideline.

The 29-year-old had three sacks in eight games this season, his fourth in Tampa Bay, but Thursday night might have been one of his best performances of the season — with a sack, three tackles for a loss, four combined tackles and a 21.1% pressure rate prior to leaving the game.

The Buccaneers surrendered three touchdowns after Barrett left the game in the third quarter. He was replaced by Anthony Nelson, who had five sacks last season.

A two-time Pro Bowler, Barrett has been the Buccaneers’ top edge rusher since his breakout season in 2019, when he led the NFL with an astounding 19.5 sacks. Barrett’s 40.5 sacks are the fourth most of any defensive player since 2019, just behind Aaron Donald, as are his 12 forced fumbles.

Barrett’s injury couldn’t come at a worse time for Tampa Bay. The Buccaneers have dropped five out of their past six games and have fallen to a 3-5 record. Their once-top-ranked run defense has given up 632 rushing yards over the past four weeks — the most in the NFL — and the unit has struggled to pressure opposing quarterbacks.

Next week, the Bucs face the defending Super Bowl champion Los Angeles Rams, whom they have lost to three times since 2020, including a 30-27 loss in January that knocked the Buccaneers out of the postseason.

Read original article here

Sports

New York Giants lose promising WR Collin Johnson to torn Achilles

Leave a comment

EAST RUTHERFORD, N.J. — The New York Giants lost wide receiver Collin Johnson for the season Wednesday on the same day that veteran Sterling Shepard returned to the practice field.

Johnson tore his Achilles tendon during Wednesday’s practice, per the team. The big receiver (6-foot-6, 220 pounds) out of the University of Texas had been receiving first-team reps in recent weeks at practice with Kadarius Toney and Shepard among those on the sideline.

Coach Brian Daboll had noted earlier in the week that Johnson and fellow wide receiver David Sills were making a strong impression. Johnson started Sunday’s preseason win over the Cincinnati Bengals and had three receptions for 41 yards; Sills had five catches for 56 yards, with most of the damage coming with the first-string offense.

“Collin Johnson, David Sills, they’ve stepped their game up,” Daboll said. “And they’re right in the mix, not just to make a team but to play.”

The Giants’ opener is in 18 days in Tennessee. Toney (right leg), C.J. Board (ribs) and Darius Slayton are also dealing with minor injuries.

Shepard, meanwhile, was making his way back from a torn Achilles suffered last December. He returned to practice for the first time Wednesday since the injury.

“It felt great, man,” said Shepard, who snuck in some reps during live drills and even caught a 20-yard pass from backup quarterback Tyrod Taylor. “Just being back on the field, it’s a blessing. Especially when you go through an injury like that and you’ve been on the sidelines for so long watching those guys get after it. You have to take every day and cherish them because you never know when you’re going to have to sit out that long.”

It had been eight months and five days since Shepard tore his Achilles. He is the longest-tenured Giant and has 349 catches for 3,884 yards and 21 touchdowns in his career, all in New York.

Shepard’s return made it appear as if the Giants were actually getting healthier at the position. Toney, Board and Slayton participated in the early portions of Wednesday’s practice.

But Toney was seen grabbing at the back of his leg during the workout, and Johnson and Marcus Kemp (hamstring) suffered significant injuries. Both Johnson and Kemp landed on injured reserve later in the day.

The Giants claimed wide receivers Bailey Gaither and Jaylon Moore on Wednesday to fill the voids. They cut tight end Jordan Akins to make room on the roster.

Johnson, 24, has 29 catches for 377 yards in 26 career games with the Jacksonville Jaguars and Giants. He made his mark with the Giants last year as a blocker.

But this summer it appeared he had taken his game to the next level. He was making plays consistently throughout training camp, earning him the trust of starting quarterback Daniel Jones and some first-team reps.

Johnson even had 10 catches for 123 receiving yards in the first two preseason games this season. With Toney still banged up and Shepard coming back from a serious injury, it looked possible that Johnson could have started — or at least played a substantial role — Week 1 against the Tennessee Titans. Instead his season came to a premature end.

Read original article here

Sports

Cleveland Browns fear torn Achilles for WR/KR Jakeem Grant

Leave a comment

BEREA, Ohio — Cleveland Browns wide receiver and kick returner Jakeem Grant Sr. suffered what the team fears is a torn Achilles, a league source told ESPN.

Grant had to be carted off the field during Tuesday’s practice after suffering the injury in the drill. A source said the team is awaiting imaging to confirm the Achilles tear.

The Browns signed Grant to a three-year deal this offseason to be their kick and punt returner; Grant, however, was also having a standout training camp as a receiver out of the slot, as well.

Grant, a Pro Bowl returner for the Chicago Bears last season, has four punt return touchdowns and two scores off kick returns during a career that began with the Miami Dolphins in 2016.

Earlier this week, Browns special teams coordinator Mike Priefer said he thought Grant would “transform” Cleveland’s return game.

If Grant is out, the Browns will likely turn to Demetric Felton to return punts and kicks for them.

Read original article here

Sports

MRI on leg shows some damage but not to Achilles

Leave a comment

BOSTON — Houston Astros pitcher Jake Odorizzi says an MRI on his left leg showed damage that will sideline him for an indefinite period, but he added he felt fortunate an injury at Fenway Park this week wasn’t worse.

Odorizzi heard a pop in his left ankle during Monday night’s start against Boston that caused him to collapse after throwing a pitch. The 32-year-old right-hander feared a serious setback with the Achilles tendon.

Odorizzi was stretchered off the field in the fifth inning of the 6-3 loss after the injury and was put on the 15-day injured list Tuesday. Right-hander Seth Martinez was recalled from Triple-A Sugar Land to take his place on the active roster. Martinez pitched in relief Tuesday night during Houston’s 13-4 win, allowing one hit over three scoreless innings.

Odorizzi said an MRI revealed some damage to tendons and ligaments but not the Achilles tendon. He said the current plan calls for pain management, rehab to improve range of motion and strengthening.

There is no set timeline for his return.

“I think the stretcher made it worse than it actually was,” Odorizzi told reporters prior to Wednesday’s series finale with the Red Sox. “It was just a quick, loud pop. I heard it and felt it, so I kind of thought it was the worst-case scenario.”

Avoiding what would have been a season-ending injury was as positive an outcome as he could have hoped for, he said.

“We got imaging done yesterday and it came back — there’s no damage to my Achilles, so that’s really the main takeaway. There’s some other damage in there, but not on the Achilles itself,” Odorizzi said. “We avoided that, and I’d say it’s the best-case scenario at that point.”

Odorizzi is 3-2 with a 3.13 ERA and 21 strikeouts in seven starts this season.

Read original article here

Sports

New York Jets DE Carl Lawson expects to be ready for training camp after tearing Achilles last year

Leave a comment

FLORHAM PARK, N.J. — Nine months removed from Achilles surgery, New York Jets defensive end Carl Lawson won’t participate in OTA practices later this month, but he expects to be on the field for training camp in late July.

“I think I’ll be good to go, but it’s up to the organization and how they want to play it, what they want me doing and stuff like that,” Lawson said Wednesday on a Zoom call with reporters, his first interview since December. “I’ll be ready to go when my number is called. Even when I was on one leg, I was ready to go.”

Lawson is sprinting, according to coach Robert Saleh, but he’s still in the latter stages of his rehab. The team will be cautious with Lawson, their marquee free-agent signing in 2021, which means there could be a ramp-up period once camp begins.

The Jets had big expectations for Lawson after signing him to a three-year, $45 million contract, but he tore his Achilles last Aug. 20 in a joint practice with the Green Bay Packers. He was finished before the season got started. The defense struggled without him, finishing 32nd in yards allowed, 32nd in scoring and 26th in sacks.

This is a difficult injury for any player, let alone a pass-rusher who relies on first-step quickness, but Lawson is confident he can regain his old form.

“I’ve had major injuries before and I came back better,” said Lawson, who has rebounded from two ACL injuries. “This is different, but I don’t plan on not being better than I was. … But if I don’t, who knows? But I plan on being better than I was.”

Lawson dominated training camp before the injury, and he’s planning to go to school on that film. That, he believes, will provide a baseline for when he’s back on the field.

“Carl is a monster,” Jets tight end C.J. Uzomah said of his former Bengals and Auburn teammate. “He’s built like an action figure. If you go on Madden and try to build a player, that is Carl. Playing with him for six years, seven years, however long it is, he’s just a freak. His get-off is unbelievable, and, in my opinion, his biggest strength is his strength. To get him back on the field, our defensive line is going to be really freaking good.”

Perhaps as insurance, the Jets have added a handful of defensive ends, most notably first-round pick Jermaine Johnson II and former Houston Texans pass-rusher Jacob Martin. They also re-signed veteran Vinny Curry, who missed last season due to complications from a blood disorder.

Lawson and John Franklin-Myers project as the starting ends, with Franklin-Myers having the flexibility to play tackle. Solomon Thomas, a free-agent acquisition, also has inside-outside versatility. Quinnen Williams and Sheldon Rankins are the top returning tackles.

“I think the potential is out the roof,” Lawson said. “I love this group. There’s a bunch of guys with different backstories. It’s going to be a competitive group, so it’s going to create a breeding ground for absolute monsters.”

Read original article here

Sports

David Ojabo selected by Baltimore Ravens in second round of NFL draft exactly 6 weeks after Achilles injury

Leave a comment

OWINGS MILLS, Md. — David Ojabo said “it means the world” to him to get drafted by the Baltimore Ravens in the second round Friday, which was exactly six weeks to the day that he suffered a devastating Achilles injury at his Michigan pro day.

Ojabo was considered a potential top-10 pick in this year’s NFL draft before he suffered the injury in a positional drill on March 18 and crashed to the ground, where he clutched his left leg in pain. At the time, he was ESPN’s Mel Kiper Jr.’s top-rated outside linebacker prospect.

When he was selected with the No. 45 overall pick, Ojabo closed his eyes, tilted his head back and let out a scream. Then, he hugged family members while tears ran down his face.

“You’ve seen it, it was raw emotion. Every second of that, I felt it,” Ojabo said. “Just being surrounded by friends and family. It’s a moment I’ll never forget.”

Pass rush is the Ravens’ biggest need, but there is a chance that Baltimore won’t see Ojabo on the field until 2023. It’s possible that Ojabo will have to sit out this season.

Ojabo, who was wearing a protective boot around his left foot and sat on a couch Friday, said he is still hopeful to play in 2022.

“I’m definitely hopeful,” he said. “But I can’t predict the future. So, I’m just day by day, do as I’m told and hope for the best.”

Ojabo said that was his first-ever injury.

“It’s a bump in the road,” he said. “Just another obstacle that I’m going to conquer.”

Ravens general manager Eric DeCosta said the team’s doctors haven’t seen Ojabo since the medical recheck but they’re “optimistic that at some point this year he’ll have a chance to play.”

DeCosta acknowledged that he thought Ojabo would be a viable first-round pick for the Ravens after watching him play in the fall.

Last season, Ojabo delivered a career-best 11 sacks and five forced fumbles (which led all Power 5 players) in his only full season of college football.

Ojabo heads to Baltimore, where he has a lot of familiarity. When healthy, he will team with former high school teammate Odafe Oweh, the Ravens’ first-round pick from a year ago, to form a promising pass-rush tandem.

On his Instagram, Odafe posted: “I’d bouta be a movie!!”

Ojabo also reunites with Ravens defensive coordinator Mike Macdonald, who served as his defensive coordinator at Michigan last season.

“It’s all part of the plan,” Ojabo said. “What are the odds that the person that comes in and gives me a chance to play, ultimately is the guy I’m following to the next level as well. It’s meant to be.”

Read original article here

Health

Could Cancer Cells’ Iron Addiction Be Their Achilles Heel?

Leave a comment

A new study from researchers at the University of California, San Francisco (UCSF) has found that cells carrying oncogenic KRAS mutations harbor elevated levels of a specific kind of iron. This iron could be used to activate drugs that target cancer cells, avoiding harm to normal, healthy cells.

Cancer therapies limited by toxicity

The formation of cancerous tumors is driven by genes known as oncogenes, the most well-known being KRAS, found in 20% of human cancers. These genes are particularly common in acute myeloid leukemia, lung adenocarcinoma and pancreatic ductal adenocarcinoma (PDA). When mutated, KRAS genes are implicated in uncontrollable cell proliferation and cell signaling, processes that ultimately enhance the survival of cancer cells. Pharmacological drugs have been developed with the aim of blocking these pathways and the subsequent proteins produced by KRAS genes. However, such therapeutics are limited in their ability to target cancer cells specifically, resulting in damage to healthy cells and tissues.

“For example, inhibitors of the MEK1/2 enzymes have shown clinical benefit, but the approach suffers from dose-limiting toxicities in the eye, skin, gut and other organs,” Dr. Eric A. Collisson, a professor in the department of medicine at UCSF said in a news release. Collisson is a co-author on a new paper published in the Journal of Experimental Medicine that explores a using cancer cells’ iron homeostasis as an approach to overcome these issues. “We sought to make cancer drugs more tolerable to patients so they can be given at higher doses and for a longer period of time,” Collisson told Technology Networks.

Cancer cells “addicted” to iron

Metal ion homeostasis has been a growing area of research in the cancer field over recent years. For this study, the UCSF research team leveraged new discoveries that cancer cells harbor elevated levels of a specific type of iron, Fe2+. “Ferrous iron [Fe2+] can donate electrons in biochemical reactions the cancer cell needs to survive and is therefore an essential cofactor in many enzymes,” Collison said.

Transcriptional studies had demonstrated that KRAS-driven tumors present with increased expression of genes are implicated in iron uptake and metabolism. Focusing on PDA specifically, they found that this increased iron concentration was correlated with shorter survival times in patients.

The jury is still out as to why KRAS-driven tumors show increased iron uptake and metabolism, Collisson explained: “We have found most cancers, and especially those with activated KRAS, harbor elevated levels of ferrous iron, likely to meet the elevated metabolic needs the cancer cell. Many of the enzymes required for DNA synthesis and repair for example require iron as an essential co-factor.”

The UCSF team hypothesized that it might be possible to utilize this feature of PDA cancer cells to their advantage. Could they be selectively targeted by drugs that are activated by ferrous iron, termed ferrous iron-activatable drug conjugates (FeADCs)? “Briefly, these are our modern versions of time proven drugs whose utility has been limited by an unwanted toxicity. By making iron activated versions of these drugs (i.e., FeADCs), we inactivate them in healthy tissues. Cancer cells preferentially activate the FeADCs due to their high iron levels,” Collisson said.

Selectively targeting iron hungry cancer cells

To test their hypothesis, the scientists synthesized a FeADC version of a US Food and Drug Administration (FDA)-approved MEK inhibitor, cobimetinib, which they named TRX-cobimetnib. To create the drug, the team first identified a specific component of the drug molecule at which synthetic introduction of an iron sensor would inactivate the drugs activity temporarily but wouldn’t affect its distribution.

Through a series of in vitro and in vivo experiments, they tested whether the FeADC would be able to disprupt KRAS signaling pathways and block cancer cell growth, without eliciting adverse effects to healthy cells and tissues. The in vivo approaches used mouse models of KRAS-driven cancer, like PDA and lung adenocarcinoma. “In general, the models of pancreatic and lung cancer that we used in this study are difficult to treat, just like the clinical disease,” Collisson said when asked to discuss the validity of the models against human cancer.

Across the in vitro and in vivo experiments, the scientists found that TRX-cobimetinib inhibited tumor growth to the same standard as cobimetinib without causing damage to healthy cells. As such, they combined TRX-cobimetinib with other anticancer drugs and discovered that the combination of therapeutics was even more effective at inhibiting tumor growth, again, without adverse side effects.

“The modifications we make to drugs will likely have effects on their solubility, distribution and to some extent excretion. These will need to be studied and optimized in animals and then people for each candidate,” Collisson noted.

The team’s positive results have led to their FeADC technology being licensed by a commercial company that will conduct human studies, likely in two to three years, according to Collisson.

As for the UCSF team, they are focused on further exploring the mechanisms that cancer cells use to elevate ferrous iron, and whether this action can be pharmacologically augmented to further intensify the effects of FeDACs.

Dr. Eric Collisson was speaking to Molly Campbell, Senior Science Writer for Technology Networks.

Reference: Jiang H, Muir R, Gonciarz R et al. Ferrous iron–activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors. Journal of Experimental Medicine. 2022. doi: 10.1084/jem.20210739

  

Read original article here

Health

Possible Achilles’ Heel Discovered for Respiratory Viruses – Like COVID-19 – That Hijack Immune Mechanisms

Leave a comment

One viral protein could provide information to deter pneumonia causing the body’s exaggerated inflammatory response to respiratory viruses, including the virus that causes (function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.6"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

Read original article here

Sports

Report: Justice Hill tore his Achilles

Leave a comment

Getty Images

After the Ravens lost J.K. Dobbins for the season, head coach John Harbaugh said he had “full confidence” in the ability of the other backs on hand to carry the load.

Losing another running back for the year may be pushing the team toward adding outside help. Ian Rapoport of NFL Media reports that Justice Hill tore his Achilles in practice.

The report came shortly after the league’s daily wire brought word that the team worked out veterans Le’Veon Bell and Devonta Freeman. Elijah Holyfield, who spent offseason time with the Eagles this year, also worked out for the Ravens.

Todd Gurley also visited the team earlier this year and they could revisit that option with Gus Edwards and Ty’Son Williams currently left as the only two backs on the active roster.



Read original article here

The Ultimate News Site